|
Volumn 42, Issue 2, 2006, Pages 260-261
|
Universal access to antiretroviral therapy: When, not if
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
COHORT ANALYSIS;
DRUG CHOICE;
DRUG COST;
HEALTH CARE ACCESS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTERNATIONAL COOPERATION;
NOTE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
UGANDA;
VIRUS INFECTION;
VIRUS LOAD;
VIRUS RESISTANCE;
WORLD HEALTH ORGANIZATION;
AFRICA SOUTH OF THE SAHARA;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
HEALTH SERVICES ACCESSIBILITY;
HIV INFECTIONS;
HUMANS;
|
EID: 30144444064
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/499062 Document Type: Note |
Times cited : (5)
|
References (8)
|